Betulinic Acid Induces Apoptosis in Differentiated PC12 Cells Via ROS-Mediated Mitochondrial Pathway

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Betulinic acid (BA), a natural pentacyclic triterpene, exhibits diverse biological activities, including anti-cancer effects by inducing apoptosis.
• The impact of BA on normal cells, particularly neurons, remains largely uncharacterized.
• Understanding BA's effects on healthy neuronal cells is crucial for assessing its therapeutic potential and safety.

Purpose of the Study:

• To investigate the effects of Betulinic acid (BA) on apoptosis in normal neuronal cells.
• To elucidate the underlying molecular mechanisms of BA-induced apoptosis in differentiated PC12 cells.
• To determine the role of reactive oxygen species (ROS) in BA-induced neuronal cell apoptosis.

Main Methods:

• Differentiated PC12 cells were used as a model for normal neuronal cells.
• Cells were treated with 50 μM Betulinic acid (BA) for 24 hours.
• Apoptosis was assessed by measuring reactive oxygen species (ROS) levels, mitochondrial membrane potential, cytochrome c release, and caspase-3 activation.
• The effect of antioxidants on BA-induced apoptosis was evaluated.

Main Results:

• Betulinic acid (BA) treatment significantly induced apoptosis in differentiated PC12 cells.
• An increase in intracellular reactive oxygen species (ROS) was observed in the early stages of BA-induced apoptosis.
• BA treatment led to the loss of mitochondrial membrane potential, release of cytochrome c, and activation of caspase-3.
• Antioxidant treatment effectively reduced BA-induced PC12 cell apoptosis.

Conclusions:

• Betulinic acid (BA) induces apoptosis in differentiated PC12 neuronal cells.
• The mechanism involves the generation of reactive oxygen species (ROS) and subsequent activation of the mitochondrial apoptotic pathway.
• BA's effects on normal neuronal cells highlight potential safety concerns and warrant further investigation for therapeutic applications.